ES2105698T3 - Oligonucleotidos modificados con 7-deazapurina. - Google Patents
Oligonucleotidos modificados con 7-deazapurina.Info
- Publication number
- ES2105698T3 ES2105698T3 ES94913923T ES94913923T ES2105698T3 ES 2105698 T3 ES2105698 T3 ES 2105698T3 ES 94913923 T ES94913923 T ES 94913923T ES 94913923 T ES94913923 T ES 94913923T ES 2105698 T3 ES2105698 T3 ES 2105698T3
- Authority
- ES
- Spain
- Prior art keywords
- deazapurine
- oligonucleotides modified
- oligonucleotides
- modified
- deazanucleosides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000692 anti-sense effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
LOS OLIGONUCLEOTIDOS, QUE TIENEN INCORPORADOS 7DEAZANUCLEOSIDOS, SON UTILES COMO SECUENCIAS ANTISENTIDO PARA INHIBIR LA FUNCION DEL ARN Y DEL ADN.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4015893A | 1993-03-30 | 1993-03-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2105698T3 true ES2105698T3 (es) | 1997-10-16 |
Family
ID=21909441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94913923T Expired - Lifetime ES2105698T3 (es) | 1993-03-30 | 1994-03-21 | Oligonucleotidos modificados con 7-deazapurina. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0691980B1 (es) |
| JP (1) | JPH08508493A (es) |
| AT (1) | ATE154029T1 (es) |
| AU (1) | AU6589094A (es) |
| CA (1) | CA2159630A1 (es) |
| DE (1) | DE69403642T2 (es) |
| DK (1) | DK0691980T3 (es) |
| ES (1) | ES2105698T3 (es) |
| GR (1) | GR3024597T3 (es) |
| HU (1) | HU9501963D0 (es) |
| WO (1) | WO1994022892A1 (es) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4438918A1 (de) | 1994-11-04 | 1996-05-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
| US6150510A (en) | 1995-11-06 | 2000-11-21 | Aventis Pharma Deutschland Gmbh | Modified oligonucleotides, their preparation and their use |
| US6906185B1 (en) | 1997-03-20 | 2005-06-14 | Amersham Biosciences Corp. | Derivatives of 7-deaza -2′-deoxyguanosine-5'-triphosphate, preparation and use thereof |
| EP0866070A1 (en) * | 1997-03-20 | 1998-09-23 | Amersham Pharmacia Biotech Inc | Derivatives of 7 deaza 2' deoxy guanosine 5' triphosphate, preparation and use thereof |
| US6660845B1 (en) * | 1999-11-23 | 2003-12-09 | Epoch Biosciences, Inc. | Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| AU2001247414A1 (en) | 2000-03-14 | 2001-09-24 | Active Motif | Oligonucleotide analogues, methods of synthesis and methods of use |
| US6962906B2 (en) | 2000-03-14 | 2005-11-08 | Active Motif | Oligonucleotide analogues, methods of synthesis and methods of use |
| JP2004509970A (ja) * | 2000-09-26 | 2004-04-02 | ハイブリドン・インコーポレイテッド | 位置的化学変化による免疫刺激オリゴヌクレオチドアナログの免疫刺激活性の調節 |
| DK2171088T3 (en) | 2007-06-19 | 2016-01-25 | Stratos Genomics Inc | Nucleic acid sequencing in a high yield by expansion |
| EP2391726B1 (en) | 2009-01-29 | 2015-09-23 | Stratos Genomics Inc. | High throughput nucleic acid sequencing by expansion and related methods |
| WO2012003330A2 (en) | 2010-06-30 | 2012-01-05 | Stratos Genomics, Inc | Multiplexed identification of nucleic acid sequences |
| US8916344B2 (en) | 2010-11-15 | 2014-12-23 | Exact Sciences Corporation | Methylation assay |
| US8361720B2 (en) | 2010-11-15 | 2013-01-29 | Exact Sciences Corporation | Real time cleavage assay |
| US9212392B2 (en) | 2012-09-25 | 2015-12-15 | Exact Sciences Corporation | Normalization of polymerase activity |
| US20140287946A1 (en) | 2013-03-14 | 2014-09-25 | Ibis Biosciences, Inc. | Nucleic acid control panels |
| US10184154B2 (en) | 2014-09-26 | 2019-01-22 | Mayo Foundation For Medical Education And Research | Detecting cholangiocarcinoma |
| HK1244813A1 (zh) | 2014-11-20 | 2018-08-17 | F. Hoffmann-La Roche Ag | 氰脲酸酯磷醯胺酯及其衍生物，其用途和合成 |
| EP3274440B1 (en) | 2015-03-27 | 2026-03-04 | Exact Sciences Corporation | Detecting esophageal disorders |
| KR102811214B1 (ko) | 2015-10-30 | 2025-05-27 | 이그잭트 사이언시즈 코포레이션 | 복합 증폭 검출 분석 및 혈장으로부터 dna의 분리 및 검출 방법 |
| EP3904528A1 (en) | 2015-11-16 | 2021-11-03 | Stratos Genomics Inc. | Dp04 polymerase variants |
| CA3022911A1 (en) | 2016-05-05 | 2017-11-09 | Exact Sciences Development Company, Llc | Detection of lung neoplasia by analysis of methylated dna |
| JP7289264B2 (ja) | 2017-01-27 | 2023-06-09 | エグザクト サイエンシーズ コーポレーション | メチル化ｄｎａの分析による結腸腫瘍の検出 |
| US11261440B2 (en) | 2017-02-21 | 2022-03-01 | Osaka University | Antisense oligonucleic acid |
| ES2987024T3 (es) | 2017-05-04 | 2024-11-13 | Hoffmann La Roche | Variantes de polimerasa DP04 |
| US11530392B2 (en) | 2017-12-11 | 2022-12-20 | Stratos Genomics, Inc. | DPO4 polymerase variants with improved accuracy |
| US10648025B2 (en) | 2017-12-13 | 2020-05-12 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay II |
| CN114651070A (zh) | 2019-09-16 | 2022-06-21 | 精密科学公司 | 结构和温度依赖性瓣状核酸内切酶底物 |
| US20220403450A1 (en) | 2021-06-03 | 2022-12-22 | Illumina Software, Inc. | Systems and methods for sequencing nucleotides using two optical channels |
| US20240293816A1 (en) | 2021-07-01 | 2024-09-05 | Illumina, Inc. | Device having horizontal nanochannel for nanopore sequencing |
| WO2023034079A1 (en) | 2021-09-01 | 2023-03-09 | Illumina Software, Inc. | Amplitude modulation for accelerated base calling |
| JP2024534436A (ja) | 2021-09-22 | 2024-09-20 | イルミナ インコーポレイテッド | ナノポアを使用したポリヌクレオチドの配列決定 |
| US12455277B2 (en) | 2021-09-30 | 2025-10-28 | Illumina, Inc. | Isolation of cells in a nanopore sensor array |
| WO2023086391A1 (en) | 2021-11-15 | 2023-05-19 | Illumina, Inc. | Nanopore systems and methods of fabrication |
| US20230183799A1 (en) | 2021-12-10 | 2023-06-15 | Illumina, Inc. | Parallel sample and index sequencing |
| KR20240161668A (ko) | 2022-03-15 | 2024-11-12 | 일루미나, 인코포레이티드 | 페어드-엔드 시퀀싱 |
| US20230357307A1 (en) | 2022-05-04 | 2023-11-09 | Illumina, Inc. | Cleavable cyclic loop nucleotides for nanopore sequencing |
| WO2023239660A1 (en) | 2022-06-07 | 2023-12-14 | Illumina Software, Inc. | Methods and systems for identifying gene variants |
| KR20250034300A (ko) | 2022-07-07 | 2025-03-11 | 일루미나, 인코포레이티드 | 재조합 이벤트를 검출하기 위한 방법 및 시스템 |
| EP4552124A2 (en) | 2022-07-07 | 2025-05-14 | Illumina, Inc. | Methods and systems for determining copy number variant genotypes |
| US20260011403A1 (en) | 2022-09-26 | 2026-01-08 | Illumina, Inc. | Detecting and genotyping variable number tandem repeats |
| EP4594749A1 (en) | 2022-09-28 | 2025-08-06 | Illumina, Inc. | Fast pulsing for nanopore sensors |
| WO2024163233A1 (en) | 2023-01-31 | 2024-08-08 | Illumina, Inc. | Copy number variant calling and recovery |
| EP4677598A1 (en) | 2023-03-10 | 2026-01-14 | Illumina, Inc. | K-mer-based methods for assembling polynucleotide sequences |
| CN121285637A (zh) | 2023-05-03 | 2026-01-06 | 伊鲁米纳公司 | 纳米孔测序中的受控多核苷酸易位 |
| WO2024249253A1 (en) | 2023-05-31 | 2024-12-05 | Illumina, Inc. | Detecting tandem repeats and determining copy numbers thereof |
| WO2025006464A1 (en) | 2023-06-30 | 2025-01-02 | Illumina, Inc. | Systems and methods of sequencing polynucleotides with alternative scatterplots |
| WO2025006466A1 (en) | 2023-06-30 | 2025-01-02 | Illumina, Inc. | Systems and methods of sequencing polynucleotides with four labeled nucleotides |
| WO2025006460A1 (en) | 2023-06-30 | 2025-01-02 | Illumina, Inc. | Systems and methods of sequencing polynucleotides with modified bases |
| WO2025061942A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Sequencing error identification and correction |
| WO2025061922A1 (en) | 2023-09-20 | 2025-03-27 | Illumina, Inc. | Methods for sequencing |
| US20250109433A1 (en) | 2023-09-22 | 2025-04-03 | Illumina, Inc. | Macromolecule blocks for nanopore sequencing |
| WO2025072047A1 (en) | 2023-09-29 | 2025-04-03 | Illumina, Inc. | Methods and systems for determining a cyp2a6 genotype |
| WO2025072468A1 (en) | 2023-09-29 | 2025-04-03 | Illumina, Inc. | Methods and systems for estimating copy numbers and detecting variants |
| WO2025072861A1 (en) | 2023-09-29 | 2025-04-03 | Illumina, Inc. | Cleavable cyclic loop nucleotides for nanopore sequencing |
| WO2025082960A1 (en) | 2023-10-18 | 2025-04-24 | F. Hoffmann-La Roche Ag | Dpo4 polymerase variants with improved properties |
| WO2025149478A1 (en) | 2024-01-12 | 2025-07-17 | F. Hoffmann-La Roche Ag | Compositions of modified nucleoside triphosphates |
| WO2025149479A1 (en) | 2024-01-12 | 2025-07-17 | Roche Diagnostics Gmbh | Synthesis of modified nucleoside triphosphates |
| WO2025159980A1 (en) | 2024-01-23 | 2025-07-31 | Illumina, Inc. | Ratchet-chelators as unique barcodes for nanopore sequencing |
| WO2025174659A1 (en) | 2024-02-12 | 2025-08-21 | Illumina, Inc. | Net-zero current scheme for nanopore system |
| WO2025174660A1 (en) | 2024-02-12 | 2025-08-21 | Illumina, Inc. | Recharging for nanopore system |
| WO2025183909A1 (en) | 2024-03-01 | 2025-09-04 | Illumina, Inc. | Ribose-mediated cyclic loop opening for nanopore sequencing |
| WO2025184183A1 (en) | 2024-03-01 | 2025-09-04 | Illumina, Inc. | Designer peptide cyclic loops for nanopore sequencing |
| WO2025190902A1 (en) | 2024-03-13 | 2025-09-18 | Illumina, Inc. | Improving base calling quality scores |
| WO2025245014A1 (en) | 2024-05-24 | 2025-11-27 | Illumina, Inc. | Nuclease assisted nanopore sequencing |
| WO2025250322A1 (en) | 2024-05-31 | 2025-12-04 | Illumina, Inc. | Genotyping for tandem repeats |
| WO2025254714A1 (en) | 2024-06-03 | 2025-12-11 | Illumina, Inc. | System and method for assembling a polynucleotide sequence |
| WO2026043922A1 (en) | 2024-08-21 | 2026-02-26 | Illumina, Inc. | Modified nucleotides and related methods for nanopore sequencing |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3739366A1 (de) * | 1987-04-10 | 1988-10-27 | Boehringer Mannheim Gmbh | Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel |
-
1994
- 1994-03-21 DK DK94913923.2T patent/DK0691980T3/da active
- 1994-03-21 DE DE69403642T patent/DE69403642T2/de not_active Expired - Fee Related
- 1994-03-21 JP JP6522134A patent/JPH08508493A/ja active Pending
- 1994-03-21 WO PCT/US1994/002996 patent/WO1994022892A1/en not_active Ceased
- 1994-03-21 AT AT94913923T patent/ATE154029T1/de not_active IP Right Cessation
- 1994-03-21 AU AU65890/94A patent/AU6589094A/en not_active Abandoned
- 1994-03-21 HU HU9501963A patent/HU9501963D0/hu unknown
- 1994-03-21 EP EP94913923A patent/EP0691980B1/en not_active Expired - Lifetime
- 1994-03-21 CA CA002159630A patent/CA2159630A1/en not_active Abandoned
- 1994-03-21 ES ES94913923T patent/ES2105698T3/es not_active Expired - Lifetime
-
1997
- 1997-09-02 GR GR970402241T patent/GR3024597T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0691980B1 (en) | 1997-06-04 |
| HU9501963D0 (en) | 1995-08-28 |
| DE69403642T2 (de) | 1998-01-08 |
| DK0691980T3 (da) | 1997-12-29 |
| EP0691980A1 (en) | 1996-01-17 |
| ATE154029T1 (de) | 1997-06-15 |
| JPH08508493A (ja) | 1996-09-10 |
| WO1994022892A1 (en) | 1994-10-13 |
| GR3024597T3 (en) | 1997-12-31 |
| AU6589094A (en) | 1994-10-24 |
| DE69403642D1 (de) | 1997-07-10 |
| CA2159630A1 (en) | 1994-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2105698T3 (es) | Oligonucleotidos modificados con 7-deazapurina. | |
| ATE225369T1 (de) | Doppelsträngige peptidenukleinsäuren | |
| DE69838449D1 (de) | Aminooxy-modifizierte oligonukleotide | |
| CY1110633T1 (el) | Τροποποιηση αντιθετης φορας της εκφρασης σουρβιβινης | |
| DE69533697D1 (de) | ANTISENSE OLIGONUKLEOTIDMODULATION DER raf GENEXPRESSION | |
| ATE213019T1 (de) | Chimäre oligomere mit einer rns- spaltungsaktivität | |
| ATE252639T1 (de) | Modifizierter, das dorsalgewebe beeinflussender faktor | |
| DE69736840D1 (de) | Synthese von nukleosiden und polynukleotiden | |
| EP1123414A4 (en) | ANTISENSE MODULATION OF THE EXPRESSION OF INTEGRIN ALPHA 4 | |
| ATE275956T1 (de) | Veränderung der dns methyltransferase durch kombinationstherapie | |
| BR9401355A (pt) | Oligonucleotídeo e nucleotídeo. | |
| ATE163973T1 (de) | Antisense oligonukleotidhemmung von papillomavirus | |
| WO2000029623A3 (en) | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | |
| FI961202A0 (fi) | Grb3-3-geeni, sen variantteja ja niiden käyttöjä | |
| ATE369429T1 (de) | Strukturproteine des virus, welches die pankreas- krankheit bei fischen verursacht, und ihre verwendungen | |
| EP1163373A4 (en) | ANTISENSE MODULATION OF THE CELLULAR INHIBITANT OF THE APOPTOSIS EXPRESSION | |
| AU2487602A (en) | Isolated luciferases and the use thereof | |
| BR9801143A (pt) | Copolìmeros de bloco de siloxano inovativos com espaçamento rìgidos e uso dos mesmos. | |
| EA199900893A1 (ru) | Бактериальные плазмиды | |
| ES2187939T3 (es) | Moleculas aisladas de acido nucleico codificantes de miembros de la familia ssx y utilizaciones de las mismas. | |
| DE69726276D1 (de) | In situ herstellung von nukleosid-phosphoramiditen und ihre verwendung in der oligonukleotidsynthese | |
| ITTO940379A0 (it) | Sequenze specifiche per il dna umano. | |
| ES2056458T3 (es) | Procedimiento de estabilizacion de la hibridacion de secuencias polinucleotidicas complementarias. | |
| ITRM930628A0 (it) | Sequenza di nucleotidi codificante per l'allergene maggiore di piante appartenenti al genere parietaria, allergene e usi. | |
| MX9709596A (es) | Adn catal ??tico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 691980 Country of ref document: ES |